Invesaro

Stocks Comparison

Chemed vs Option Care Health: revenue, profit, margins and growth compared

Chemed brought in $2.5B of revenue in fiscal 2025, Option Care Health $5.6B in fiscal 2025. Revenue changed by +4.1% at Chemed and +13.0% at Option Care Health on the year before, so Option Care Health grew faster. Chemed kept 10.5% of its revenue as net profit, Option Care Health 3.7%. Free cash flow was $325.5M at Chemed and $217.1M at Option Care Health.

Open the CHE pageOpen the OPCH page

Side by side, latest fiscal year

CHEOPCH
Fiscal year endedFY2025 (December 31, 2025)FY2025 (December 31, 2025)
Revenue$2.5B$5.6B
Revenue growth+4.1%+13.0%
Net income$265.2M$207.6M
Net margin10.5%3.7%
Free cash flow$325.5M$217.1M
Free cash flow margin12.9%3.8%
Earnings per share (diluted)$18.34$1.27
Cash$74.5M$232.6M
Debtn/a$1.2B
Price to earnings27.918.2
Market value$6.7B$3.5B
Dividend yield0.43%n/a
Rank by revenue in sector#95 of 523 · Health care#58 of 523 · Health care

Over the years

Revenue
CHE FY2018: $1.8BCHE FY2019: $1.9BCHE FY2020: $2.1BCHE FY2021: $2.1BCHE FY2022: $2.1BCHE FY2023: $2.3BCHE FY2024: $2.4BCHE FY2025: $2.5BOPCH FY2018: $1.9BOPCH FY2019: $2.3BOPCH FY2020: $3BOPCH FY2021: $3.4BOPCH FY2022: $3.9BOPCH FY2023: $4.3BOPCH FY2024: $5BOPCH FY2025: $5.6BFY18FY19FY20FY21FY22FY23FY24FY25
CHE $2.5BOPCH $5.6B
Net income
CHE FY2018: $205.5MCHE FY2019: $219.9MCHE FY2020: $319.5MCHE FY2021: $268.6MCHE FY2022: $249.6MCHE FY2023: $272.5MCHE FY2024: $302MCHE FY2025: $265.2MOPCH FY2018: -$6.1MOPCH FY2019: -$75.9MOPCH FY2020: -$8.1MOPCH FY2021: $139.9MOPCH FY2022: $150.6MOPCH FY2023: $267.1MOPCH FY2024: $211.8MOPCH FY2025: $207.6MFY18FY19FY20FY21FY22FY23FY24FY25
CHE $265.2MOPCH $207.6M
Net margin
CHE FY2018: 11.5%CHE FY2019: 11.3%CHE FY2020: 15.4%CHE FY2021: 12.6%CHE FY2022: 11.7%CHE FY2023: 12.0%CHE FY2024: 12.4%CHE FY2025: 10.5%OPCH FY2018: -0.3%OPCH FY2019: -3.3%OPCH FY2020: -0.3%OPCH FY2021: 4.1%OPCH FY2022: 3.8%OPCH FY2023: 6.2%OPCH FY2024: 4.2%OPCH FY2025: 3.7%FY18FY19FY20FY21FY22FY23FY24FY25
CHE 10.5%OPCH 3.7%
Revenue growth
CHE FY2019: +8.7%CHE FY2020: +7.3%CHE FY2021: +2.9%CHE FY2022: -0.2%CHE FY2023: +6.1%CHE FY2024: +7.4%CHE FY2025: +4.1%OPCH FY2019: +19.1%OPCH FY2020: +31.3%OPCH FY2021: +13.4%OPCH FY2022: +14.7%OPCH FY2023: +9.1%OPCH FY2024: +16.2%OPCH FY2025: +13.0%FY19FY20FY21FY22FY23FY24FY25
CHE +4.1%OPCH +13.0%
Free cash flow
CHE FY2018: $234.3MCHE FY2019: $248.2MCHE FY2020: $430.5MCHE FY2021: $249.9MCHE FY2022: $252.6MCHE FY2023: $273.4MCHE FY2024: $368MCHE FY2025: $325.5MOPCH FY2018: -$1.8MOPCH FY2019: $11.2MOPCH FY2020: $100.5MOPCH FY2021: $182.9MOPCH FY2022: $232.2MOPCH FY2023: $329.4MOPCH FY2024: $287.8MOPCH FY2025: $217.1MFY18FY19FY20FY21FY22FY23FY24FY25
CHE $325.5MOPCH $217.1M

Fiscal years as each company reports them; the two may end in different months.

Questions about Chemed and Option Care Health

Which is bigger by revenue, Chemed or Option Care Health?

Option Care Health is bigger by revenue: $5.6B in fiscal 2025, against $2.5B for Chemed in fiscal 2025.

Which keeps more of its revenue as profit, Chemed or Option Care Health?

Chemed had a net margin of 10.5% in fiscal 2025; Option Care Health had 3.7% in fiscal 2025.

Which grew revenue faster, Chemed or Option Care Health?

In their latest fiscal years revenue changed by +4.1% at Chemed and +13.0% at Option Care Health.

Where do these numbers come from?

From the annual reports each company files with the SEC (10-K, or 20-F and 40-F for foreign companies), read from their XBRL data. Margins and growth are simple arithmetic on those figures. Nothing here is a recommendation.

More comparisons

BTSGU vs CHE
AHCO vs CHE
AVAH vs CHE
BTSGU vs OPCH
AHCO vs OPCH
AVAH vs OPCH

Compare more companies